MedTrace Logo

Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan

NCT00120237 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1600

Last updated 2009-03-19

No results posted yet for this study

Summary

This community-based trial will study misoprostol for the prevention of postpartum hemorrhage in rural Pakistan. Traditional birth attendants assisting home deliveries will administer study tablets (600 mcg oral misoprostol or placebo) in the third stage of labor to women participating in the trial. Blood loss, hemoglobin levels, side effects, and other variables will be evaluated.

Conditions

  • Postpartum Hemorrhage
  • Anemia

Interventions

DRUG

Misoprostol

600 mcg oral misoprostol administered during third stage of labor

Sponsors & Collaborators

  • Aga Khan University

    collaborator OTHER

  • Aga Khan Health Services

    collaborator OTHER

  • The Aga Khan Foundation

    collaborator OTHER

  • Family Care International

    collaborator OTHER

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Gijs Walraven, MD · Aga Khan Health Services

  • Juanita Hatcher, PhD · Aga Khan University

  • Naushaba Mobeen, MD · Aga Khan University

  • Jennifer Blum, MPH · Gynuity Health Projects

  • Zafar Ahmad, MD · Aga Khan Health Services

  • Nadeem Zuberi, MD · Aga Khan University

  • Jill Durocher · Gynuity Health Projects

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00120237 on ClinicalTrials.gov